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CC BY-NC-ND license (http://creativeBackground/purpose: Serum gastric parietal cell antibody (GPCA), thyroglobulin antibody
(TGA), and thyroid microsomal antibody (TMA) are found in some erosive oral lichen planus
(EOLP) patients. This study assessed whether serum GPCA, TGA and TMA and EOLP itself played
significant roles in causing anemia and hematinic deficiencies in TGA/TMA-positive EOLP pa-
tients with GPCA positivity (GPCAþ/TGA/TMA/EOLP patients) or negativity (GPCA/TGA/
TMA/EOLP patients).
Methods: The mean corpuscular volume (MCV) and mean blood hemoglobin (Hb), iron, vitamin
B12, and folic acid levels were measured and compared between any two of the four groups of
29 GPCAþ/TGA/TMA/EOLP patients, 80 GPCA/TGA/TMA/EOLP patients, 198 all antibodies-
negative EOLP patients (Abs/EOLP patients), and 218 healthy control individuals.
Results: GPCAþ/TGA/TMA/EOLP patients had significantly lower mean Hb and vitamin B12
levels as well as significantly greater frequencies of Hb, iron, and vitamin B12 deficiencies than
healthy controls. GPCAþ/TGA/TMA/EOLP patients had significantly lower serum vitamin B12
level and higher MCV as well as a significantly greater frequency of vitamin B12 deficiency than
GPCA/TGA/TMA/EOLP patients. Furthermore, both GPCA/TGA/TMA/EOLP and Abs/EOLP
patients did have significantly lower mean Hb, MCV, and iron (for women only) levels, as well
as significantly greater frequencies of Hb and iron deficiencies than healthy controls. However,
there were no significant differences in measured blood data between GPCA/TGA/TMA/EOLP
and Abs/EOLP patients.of Dentistry, National Taiwan University Hospital, Number 1, Chang-Te Street, Taipei 10048, Taiwan.
oo.com.tw (A. Sun).
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Hematinic deficiencies in oral lichen planus 1005Conclusion: We conclude that serum GPCA is the major factor causing vitamin B12 deficiency,
macrocytosis and pernicious anemia in GPCAþ/TGA/TMA/EOLP patients. ELOP itself but not
TGA/TMA positivity plays a significant role in causing anemia and hematinic deficiencies in
GPCA/TGA/TMA/EOLP patients.
Copyright ª 2016, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).Introduction
Our previous study has shown the presence of serum anti-
nuclear antibody (ANA), smooth muscle antibody (SMA),
antimitochondrial antibody (AMA), gastric parietal cell
antibody (GPCA), thyroglobulin antibody (TGA), and thyroid
microsomal antibody (TMA) in 28.4%, 8.2%, 1.7%, 26.7%,
21.2%, and 24.7% of 292 erosive oral lichen planus (EOLP)
patients.1 GPCA can induce destruction of gastric parietal
cells, resulting in failure of intrinsic factor production and
vitamin B12 deficiency that finally leads to the status of
pernicious anemia.2e5 Vitamin B12 deficiency may also be
due to insufficient intake of vitamin-B12-containing foods,
vitamin B12 malabsorption, and transcobalamin II defi-
ciency.5 Moreover, patients with TGA/TMA positivity
(including TGA positivity only, TMA positivity only, or both
TGA and TMA positivities) may have autoimmune thyroid
diseases.6 Our previous studies also showed that patients
with TGA/TMA positivity may have hypothyroidism, euthy-
roid, or hyperthyroidism.6,7 Because multiple factors are
involved in hemoglobin (Hb) deficiency (anemia) in EOLP
patients, it is interesting to know which factors (such as
GPCA positivity, TGA/TMA positivity, and EOLP itself) are
important for the development of anemia or hematinic
deficiencies in our GPCA-positive and GPCA-negative EOLP
patients with TGA/TMA positivity.
In our oral mucosal disease clinic, patients with atrophic
glossitis (AG), burning mouth syndrome (BMS), OLP, recur-
rent aphthous stomatitis (RAS), oral submucous fibrosis
(OSF), and other oral mucosal diseases are frequently
encountered.6e21 For AG, BMS, OLP, RAS, and OSF patients,
complete blood count, serum iron, vitamin B12, folic acid,
homocysteine, ANA, SMA, AMA, GPCA, TGA, and TMA levels
were frequently examined to assess whether these patients
have anemia, hematinic deficiencies and serum ANA, SMA,
AMA, GPCA, TGA, or TMA positivity.6e18 Our previous
studies discovered that 16.1%, 20.2%, 16.1%, and 4.0% of
124 GPCA-positive patients (75 AG and 49 BMS patients),
and 16.3%, 14.2%, 6.3%, and 1.1% of 190 TGA/TMA-positive
patients (83 AG and 107 BMS patients) had Hb, serum iron,
vitamin B12, and folic acid deficiencies, respectively.6,14 To
assess whether the serum GPCA, TGA, and TMA as well as
the disease of EOLP itself played significant roles in causing
anemia and hematinic deficiencies in TGA/TMA-positive
EOLP patients with GPCA positivity (GPCAþ/TGA/TMA/
EOLP patients) or negativity (GPCA/TGA/TMA/EOLP pa-
tients), 29 GPCAþ/TGA/TMA/EOLP patients without ANA,
SMA, and AMA positivity, 80 GPCA/TGA/TMA/EOLP pa-
tients without ANA, SMA, and AMA positivity, and 198 all six
aforementioned autoantibody-negative EOLP patients(Abs/EOLP patients) retrieved from our previous study
were collected.11 Their complete blood counts as well as
serum iron, vitamin B12, folic acid, and homocysteine
levels were examined and compared with the correspond-
ing data of 218 healthy control individuals. The purposes of
this study were to study the anemia statuses and hematinic
deficiencies in these 29 GPCAþ/TGA/TMA/EOLP patients
and 80 GPCA/TGA/TMA/EOLP patients and to clarify the
roles of the serum GPCA, TGA, TMA, and/or the disease of
EOLP itself in the final development of anemia and hema-
tinic deficiencies in our GPCAþ/TGA/TMA/EOLP and
GPCA/TGA/TMA/EOLP patients.Materials and methods
Patients
This study included 109 (12 men and 97 women, aged 25e82
years, mean age 53.8 12.8 years) TGA/TMA/EOLP pa-
tients, 198 (51 men and 147 women, aged 22e87 years,
mean 57 15 years) Abs/EOLP patients, and 218 healthy
control individuals (24 men and 194 women, aged 22e84
years, mean 55.2 13.4 years). The 109 TGA/TMA/EOLP
patients were further divided into 29 (3 men and 26 women,
aged 29e76 years, mean age 55.3 10.6 years) GPCAþ/
TGA/TMA/EOLP patients and 80 (9 men and 71 women,
aged 25e82 years, mean age 53.3 13.5 years) GPCA/
TGA/TMA/EOLP patients, For comparison, the correspond-
ing blood data of 198 Abs/EOLP patients were retrieved
from our previous study and included in this study.11 All the
EOLP patients and healthy control individuals were seen
consecutively, diagnosed, treated, and collected in the oral
mucosal disease clinic or dental clinic of National Taiwan
University Hospital (NTUH) from July 2007 to July 2016. OLP
was diagnosed according to the criteria described previ-
ously.1,10 However, EOLP patients with ANA, SMA, and/or
AMA positivity, areca quid chewing habit, autoimmune
diseases (such as systemic lupus erythematosus, rheuma-
toid arthritis, Sjogren syndrome, pemphigus vulgaris, and
cicatricial pemphigoid), inflammatory diseases, RAS, ma-
lignancy, or recent surgery were excluded. In addition, all
EOLP patients with serum creatinine concentrations indic-
ative of renal dysfunction (i.e., men, >131mM; women,
>115mM), and who reported a history of stroke, heavy
alcohol use, or diseases of the liver, kidney, or coronary
arteries were also excluded.22 Healthy control individuals
had either dental caries, pulpal disease, malocclusion, or
missing of teeth but did not have any oral mucosal or sys-
temic diseases. None of our included EOLP patients had
1006 J.Y.-F. Chang et al.taken any prescription medication for EOLP at least 3
months before entering the study.
The blood samples were drawn from all included EOLP
patients and healthy control participants for measurement
of complete blood count, serum iron, vitamin B12, folic
acid, and homocysteine concentrations as well as serum
ANA, SMA, AMA, GPCA, TGA, and TMA levels. All EOLP
patients and healthy control individuals gave signed
informed consent before entering the study. This study was
reviewed and approved by the Institutional Review Board at
NTUH.
Determination of complete blood count and serum
iron, vitamin B12, folic acid, and homocysteine
concentrations
The complete blood count and serum iron, vitamin B12,
folic acid, and homocysteine concentrations were deter-
mined by routine tests performed in the Department of
Laboratory Medicine of NTUH as described previously.6e18
This study defined the Hb and hematinic deficiencies ac-
cording to the World Health Organization criteria. Thus,
men with Hb< 13 g/dL and women with Hb< 12 g/dL were
defined as having Hb deficiency or anemia.23,24 Patients
with serum iron level <60 mg/dL, vitamin B12 level
<200 pg/mL or folic acid level <4 ng/mL were defined as
having iron, vitamin B12, or folic acid deficiency, respec-
tively.22,25,26 Moreover, patients with the serum homocys-
teine level >12.3mM (which was the mean serum
homocysteine level of healthy controls plus 2 standard
deviations) were defined as having abnormally high homo-
cysteine level.
Determination of serum ANA, SMA, AMA, GPCA,
TGA, and TMA levels
The methods of determination of serum ANA, SMA, AMA,
GPCA, TGA, and TMA levels in our EOLP patients and
healthy control individuals have been described in our
previous studies.1,6e9,11,13,14
Statistical analysis
Comparisons of the mean corpuscular volume (MCV) and
mean blood levels of Hb, iron, vitamin B12, folic acid, and
homocysteine between any two of the four groups of
GPCAþ/TGA/TMA/EOLP patients, GPCA/TGA/TMA/EOLP
patients, Abs/EOLP patients, and healthy control in-
dividuals were performed by Student t test. The differences
in frequency of Hb, iron, vitamin B12, or folic acid defi-
ciency, or frequency of abnormally high blood homocysteine
level between any two of the four groups of GPCAþ/TGA/
TMA/EOLP patients, GPCA/TGA/TMA/EOLP patients,
Abs/EOLP patients, and healthy control individuals were
compared by c2 test. Comparisons of MCV and mean blood
concentrations of Hb, iron, vitamin B12, folic acid, and
homocysteine between any two of the three groups of pa-
tients with macrocytic, normocytic, or microcytic red blood
cells (RBCs) were performed by Student t test. The result
was considered to be significant for p< 0.05.Results
The MCV and mean blood concentrations of Hb, iron,
vitamin B12, folic acid, and homocysteine in 29 GPCAþ/
TGA/TMA/EOLP patients, 80 GPCA/TGA/TMA/EOLP pa-
tients, 198 Abs/EOLP patients, and 218 healthy control
individuals are shown in Table 1. Because men usually had
higher blood levels of Hb and iron than women have, these
two mean levels were calculated separately for men and
women. We found significantly lower mean Hb (men,
pZ 0.008 and women, p< 0.001) and vitamin B12
(p< 0.001) levels as well as significantly higher mean blood
homocysteine level (p< 0.001) in GPCAþ/TGA/TMA/EOLP
patients than in healthy control individuals (Table 1).
Moreover, we found a significantly lower mean vitamin B12
level (pZ 0.004) and a significantly higher MCV (pZ 0.016)
or higher mean blood homocysteine level (p< 0.001) in
GPCAþ/TGA/TMA/EOLP patients than in GPCA/TGA/TMA/
EOLP patients. In addition, GPCA/TGAþ/TMAþ/EOLP pa-
tients had a significantly lower mean Hb (men, pZ 0.026
and women, p< 0.001), lower MCV (p< 0.001), and lower
mean iron (women only, p< 0.001) than healthy control
individuals had. Moreover, there were no significant dif-
ferences in MCV and blood Hb, iron, vitamin B12, folic acid,
and homocysteine levels between GPCA/TGA/TMA/EOLP
patients and Abs/EOLP patients. Furthermore, Abs/
EOLP patients had significantly lower mean Hb (men,
pZ 0.016 and women, p< 0.001), MCV (p< 0.001), iron
(women only, p< 0.001), vitamin B12 (p< 0.001), and folic
acid levels (p< 0.001) than healthy control individuals had
(Table 1).
We also found significantly greater frequencies of Hb,
iron, and vitamin B12 deficiencies and of high blood ho-
mocysteine level in GPCAþ/TGA/TMA/EOLP patients than
in healthy control individuals (all p< 0.001) (Table 2).
There were also significantly greater frequencies of vitamin
B12 deficiency and of high serum homocysteine level in
GPCAþ/TGA/TMA/EOLP patients than in GPCA/TGA/TMA/
EOLP patients (both p< 0.001). Moreover, we also demon-
strated significantly greater frequencies of Hb and iron
deficiencies in GPCA/TGA/TMA/EOLP patients (both
p< 0.001) or in Abs/EOLP patients (both p< 0.001) than in
healthy control individuals (Table 2). However, there were
no significant differences in frequencies of blood Hb, iron,
vitamin B12, and folic acid deficiencies and of high serum
homocysteine level between GPCA/TGA/TMA/EOLP pa-
tients and Abs/EOLP patients.
In this study, 9 (31.0%) of 29 GPCAþ/TGA/TMA/EOLP
patients and 17 (21.3%) of 80 GPCA/TGA/TMA/EOLP pa-
tients were diagnosed as having anemia according to the
World Health Organization criteria (Table 3).23,24 The
different anemia types of 9 anemic GPCAþ/TGA/TMA/EOLP
patients and of 17 anemic GPCA/TGA/TMA/EOLP patients
are described in detail in Table 3. In this study, pernicious
anemia was diagnosed as having MCV 100 fL, vitamin
B12< 200 pg/mL, and serum GPCA positivity,14e16 iron
deficiency anemia as having MCV< 80 fL and iron< 60 mg/
dL;23,24 and thalassemia trait as having MCV< 74 fL, RBC
count > 5.0 1012/L, and Mentzer index (MCV/RBC)< 13.27
By these definitions, of nine anemic GPCAþ/TGA/TMA/
EOLP patients, six had pernicious anemia, two had iron
Table 1 Comparisons of MCV andmean blood concentrations of Hb, iron, vitamin B12, folic acid and homocysteine between any
two of four groups of GPCAþ/TGA/TMA/EOLP, GPCAe/TGA/TMA/EOLP, and Abse/EOLP patients, and healthy control subjects.
Group Hb (g/dL) MCV (fL) Iron (mg/dL) Vitamin B12
(pg/mL)
Folic acid
(ng/mL)
Homocysteine
(mM)Men Women Men Women
GPCAþ/TGA/TMA/
EOLP patients
(nZ 29)
13.5 2.1
(nZ 3)
12.6 1.2
(nZ 26)
91.9 9.3 94.3 60.1
(nZ 3)
92.9 43.5
(nZ 26)
490.3 324.7 13.6 5.6 10.6 4.1
ap 0.008 <0.001 0.333 0.849 0.355 <0.001 0.278 <0.001
bp 0.738 0.278 0.016 0.576 0.364 0.004 0.883 <0.001
GPCA/TGA/TMA/
EOLP patients
(nZ 80)
14.0 2.2
(nZ 9)
12.9 1.2
(nZ 71)
87.2 8.7 110.8 37.3
(nZ 9)
85.5 32.0
(nZ 71)
663.7 251.6 13.8 6.5 8.2 2.8
ap 0.026 <0.001 <0.001 0.260 <0.001 0.138 0.176 0.733
cp 0.642 0.565 0.127 0.231 0.714 0.078 0.248 0.407
Abs/EOLP patients
(nZ 198)
14.3 1.7
(nZ 51)
13.0 1.2
(nZ 147)
88.7 6.8 96.2 32.7
(nZ 51)
87.1 29.2
(nZ 147)
606.6 240.5 12.9 5.6 8.5 2.7
ap 0.016 <0.001 <0.001 0.833 <0.001 <0.001 <0.001 0.388
Healthy controls
(nZ 218)
15.2 0.8
(nZ 24)
13.6 0.7
(nZ 194)
91.0 3.7 97.8 25.5
(nZ 24)
98.3 25.2
(nZ 194)
712.0 247.2 14.9 6.1 8.3 2.0
Abs/EOLP patientsZ all antibody-negative EOLP patients; EOLPZ erosive oral lichen planus; GPCAZ gastric parietal cell antibody;
GPCAþ/TGA/TMA/EOLP patientsZ TGA/TMA-positive EOLP patients with GPCA positivity; GPCA/TGA/TMA/EOLP patientsZ TGA/TMA-
positive EOLP patients with GPCA negativity; MCVZmean corpuscular volume; TGAZ thyroglobulin antibody; TMAZ thyroid micro-
somal antibody.
a Comparison between GPCAþ/TGA/TMA/EOLP, GPCA/TGA/TMA/EOLP, or Abs/EOLP patients and healthy control individuals.
b Comparison between GPCAþ/TGA/TMA/EOLP and GPCA/TGA/TMA/EOLP patients.
c Comparison between GPCA/TGA/TMA/EOLP and Abs/EOLP patients.
Hematinic deficiencies in oral lichen planus 1007deficiency anemia, and one had microcytic anemia but did
not have iron deficiency. Moreover, of 17 anemic GPCA/
TGA/TMA/EOLP patients, 10 had normocytic anemia, 4 had
iron deficiency anemia, and 3 had thalassemia trait.
When 29 GPCAþ/TGA/TMA/EOLP patients were further
divided into three groups: Group 1 (8 patients with
MCV 100 fL), Group 2 (18 patients with MCV 80e99.9 fL),
and Group 3 (3 patients with MCV< 80 fL), we found thatTable 2 Comparisons of frequencies of Hb, iron, vitamin B12,
blood homocysteine level between any two of four groups of GPC
patients, and healthy control subjects.
Group Hb deficiency
(Men <13 g/dL,
Women <12 g/dL)
Iron
(<6
GPCAþ/TGA/TMA/OLP patients (nZ 29) 9 (31.0%) 3 (1
ap <0.001 <0.
bp 0.421 0.6
GPCA/TGA/TMA/OLP patients (nZ 80) 17 (21.3%) 13 (
ap <0.001 <0.
cp 0.877 0.5
Abs/EOLP patients (nZ 198) 42 (21.2%) 25 (
ap <0.001 <0.
Healthy control individuals (nZ 218) 0 (0%) 0 (0
Abs/EOLP patientsZ all antibody-negative EOLP patients; EOLPZ e
GPCAþ/TGA/TMA/EOLP patientsZ TGA/TMA-positive EOLP patients w
positive EOLP patients with GPCA negativity; HbZ hemoglobin; MCV
oglobulin antibody; TMAZ thyroid microsomal antibody.
a Comparison between GPCAþ/TGA/TMA/EOLP, GPCA/TGA/TMA/E
b Comparison between GPCAþ/TGA/TMA/EOLP and GPCA/TGA/TM
c Comparison between GPCA/TGA/TMA/EOLP and Abs/EOLP patiGroup 1 patients had significantly lower Hb (women only,
p< 0.001), higher MCV (p< 0.001), lower mean serum
vitamin B12 level (p< 0.001), and higher mean serum ho-
mocysteine level (pZ 0.005) than Group 2 patients had
(Table 4). Moreover, Group 3 patients had significantly
lower mean Hb level (women only, p< 0.001), lower MCV
(p< 0.001), and higher mean folic acid level (pZ 0.037)
than Group 2 patients had (Table 4). In addition, Group 1and folic acid deficiencies and frequency of abnormally high
Aþ/TGA/TMA/EOLP, GPCAe/TGA/TMA/EOLP, and Abse/EOLP
deficiency
0 mg/dL)
Vitamin B12
deficiency
(<200 pg/mL)
Folic acid
deficiency
(<4 ng/mL)
High homocysteine
level (>12.3 mM)
0.3%) 9 (31.0%) 0 (0%) 11 (37.9%)
001 <0.001 ND <0.001
43 <0.001 ND <0.001
16.3%) 1 (1.3%) 0 (0%) 7 (8.8%)
001 0.601 ND 0.139
46 0.641 0.639 0.934
12.6%) 2 (1.0%) 1 (0.5%) 15 (7.6%)
001 0.437 0.962 0.127
%) 0 (0%) 0 (0%) 8 (3.7%)
rosive oral lichen planus; GPCAZ gastric parietal cell antibody;
ith GPCA positivity; GPCA/TGA/TMA/EOLP patientsZ TGA/TMA-
Zmean corpuscular volume; NDZ not determined; TGAZ thyr-
OLP, or Abs/EOLP patients and healthy control individuals.
A/OLP patients.
ents.
Table 3 Anemia in TGA/TMA/EOLP, GPCAþ/TGA/TMA/EOLP and GPCA/TGA/TMA/EOLP patients.
Anemia type Patient no. (%)
Patient no. (%) MCV (fL) Vitamin B12 deficiency
(<200 pg/mL)
Iron deficiency
(<60 mg/dL)
TGA/TMA/EOLP patients (n[ 109)
Pernicious anemia 6 (23.1) 100 6 (100.0) 0 (0.0)
Normocytic anemia 10 (38.4) 80e99.9 0 (0.0) 8 (80.0)
Iron deficiency anemia 6 (23.1) <80 1 (16.7) 6 (100.0)
Microcytic anemia 1 (15.4) <80 0 (0.0) 0 (0.0)
Thalassemia trait 3 (17.7) <74 0 (0.0) 0 (0.0)
Total 26 (100.0) 7 (26.9) 14 (53.8)
GPCAþ/TGA/TMA/EOLP patients (n[ 29)
Pernicious anemia 6 (66.7) 100 6 (100.0) 0 (0.0)
Iron deficiency anemia 2 (22.2) <80 1 (50.0) 2 (100.0)
Microcytic anemia 1 (11.1) <80 0 (0.0) 0 (0.0)
Total 9 (100.0) 7 (77.8) 2 (22.2)
GPCA/TGA/TMA/EOLP patients (n[ 80)
Normocytic anemia 10 (58.8) 80e99.9 0 (0.0) 8 (80.0)
Iron deficiency anemia 4 (23.5) <80 0 (0.0) 4 (100.0)
Thalassemia trait 3 (17.7) <74 0 (0.0) 0 (0.0)
Total 17 (100.0) 0 (0.0) 12 (70.6)
EOLPZ erosive oral lichen planus; GPCAZ gastric parietal cell antibody; GPCAþ/TGA/TMA/EOLP patientsZ TGA/TMA-positive EOLP
patients with GPCA positivity; GPCA/TGA/TMA/EOLP patientsZ TGA/TMA-positive EOLP patients with GPCA negativity; MCVZmean
corpuscular volume; TGAZ thyroglobulin antibody; TMAZ thyroid microsomal antibody.
1008 J.Y.-F. Chang et al.patients had significantly higher MCV (p< 0.001), and lower
mean serum vitamin B12 level (pZ 0.009) than Group 3
patients had (Table 4).
We also divided 80 GPCA/TGA/TMA/EOLP patients into
three groups: Group 1 (1 patient with MCV 100 fL), Group
2 (68 patients with MCV 80e99.9 fL), and Group 3 (11 pa-
tients with MCV< 80 fL). Because there was only oneTable 4 MCV and mean blood concentrations of Hb, iron, vitami
patients with MCV 100 fL (Group 1), 80e99.9 fL (Group 2), and
GPCAþ/TG
Group 1
MCV 100 fL
(nZ 8)
ap
(Group 1 vs. 2)
Group 2
MCV 80e
fL (nZ 1
Mean SD Mean S
Hb (g/dL)
Men (nZ 0) ND 14.7 0.
Women 11.5 0.6
(nZ 8)
<0.001 13.4 0.
(nZ 16)
MCV (fL) 102.8 1.9 <0.001 90.4 2.
Iron (mg/dL)
Men (nZ 0) ND 129.0 1
Women 83.0 15.6
(nZ 8)
0.310 102.3 5
(nZ 16)
Vitamin B12 (pg/mL) 171.9 18.6 < 0.001 611.1 2
Folic acid (ng/mL) 14.3 7.3 0.421 12.4 4.
Homocysteine (mM) 13.8 4.2 0.005 9.0 3.4
EOLPZ erosive oral lichen planus; GPCAZ gastric parietal cell antib
patients with GPCA positivity; HbZ hemoglobin; MCVZmean corpu
TGAZ thyroglobulin antibody; TMAZ thyroid microsomal antibody.
a Comparison of MCV and mean blood concentrations of Hb, iron, vi
Groups 2 and 3, and Groups 1 and 3 by Student t test.patient in Group 1, the blood data were compared between
Group 2 and Group 3 patients only. We found that Group 3
patients had significantly lower mean Hb level (women
only, p< 0.001), lower MCV (p< 0.001), lower mean serum
iron level (women only, pZ 0.043), and lower mean serum
folic acid level (pZ 0.024) than Group 2 patients had
(Table 5).n B12, folic acid, and homocysteine in GPCAþ/TGA/TMA/EOLP
< 80 fL (Group 3).
A/TMA/EOLP patients (nZ 29)
99.9
8)
ap
(Group 2 vs. 3)
Group 3
MCV < 80 fL
(nZ 3)
ap
(Group 1 vs. 3)
D Mean SD
9 (nZ 2) ND 11.2 (nZ 1) ND
7 <0.001 11.3 0.1
(nZ 2)
0.665
5 <0.001 71.5 5.9 <0.001
.4 (nZ 2) ND 25 (nZ 1) ND
0.8 0.254 57.5 46.0
(nZ 2)
0.178
95.5 0.987 614.3 415.7 0.009
5 0.037 18.8 5.1 0.359
0.266 11.4 3.0 0.395
ody; GPCAþ/TGA/TMA/EOLP patientsZ TGA/TMA-positive EOLP
scular volume; NDZ not determined; SDZ standard deviation;
tamin B12, folic acid, and homocysteine between Groups 1 and 2,
Table 5 MCV and mean blood concentrations of Hb, iron, vitamin B12, folic acid, and homocysteine, in GPCA/TGA/TMA/
EOLP patients with MCV 100 fL (Group 1), 80e99.9 fL (Group 2), and < 80 fL (Group 3).
GPCA/TGA/TMA/EOLP patients (nZ 80)
Group 1
MCV 100 fL
(nZ 1)
ap
(Group 1 vs. 2)
Group 2
MCV 80e99.9
fL (nZ 68)
ap
(Group 2 vs. 3)
Group 3
MCV < 80 fL
(nZ 11)
ap
(Group 1 vs. 3)
Mean SD Mean SD Mean SD
Hb (g/dL)
Men (nZ 0) ND 14.2 2.3 (nZ 8) ND 12.4 (nZ 1) ND
Women 12.7 (nZ 1) ND 13.1 1.0 (nZ 60) <0.001 11.4 1.7
(nZ 10)
ND
MCV (fL) 103.1 ND 90.1 3.6 <0.001 68.3 6.0 ND
Iron (mg/dL)
Men (nZ 0) ND 110.0 39.8 (nZ 8) ND 117 (nZ 1) ND
Women 99 (nZ 1) ND 88.5 29.6 (nZ 60) 0.043 66.4 41.5
(nZ 10)
ND
Vitamin B12 (pg/mL) 150.0 ND 663.1 249.6 0.524 714.6 231.1 ND
Folic acid (ng/mL) 24.0 ND 14.3 6.6 0.024 9.6 3.4 ND
Homocysteine (mM) 15.6 ND 8.2 2.8 0.427 7.5 1.9 ND
EOLPZ erosive oral lichen planus; GPCAZ gastric parietal cell antibody; GPCA/TGA/TMA/EOLP patientsZ TGA/TMA-positive EOLP
patients with GPCA negativity; HbZ hemoglobin; MCVZmean corpuscular volume; NDZ not determined; SDZ standard deviation;
TGAZ thyroglobulin antibody; TMAZ thyroid microsomal antibody.
a Comparison of MCV and mean blood concentrations of Hb, iron, vitamin B12, folic acid, and homocysteine between Groups 1 and 2,
Groups 2 and 3, and Groups 1 and 3 by Student t test.
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This study found that GPCAþ/TGA/TMA/EOLP patients had
significantly lower mean Hb and serum vitamin B12 level as
well as significantly higher mean serum homocysteine level
than healthy control individuals. Moreover, GPCAþ/TGA/
TMA/EOLP patients had significantly greater frequencies of
Hb, serum iron, and serum vitamin B12 deficiencies and of
high serum homocysteine level than healthy controls. These
two findings suggest that the anemia status and hematinic
deficiencies in GPCAþ/TGA/TMA/EOLP patients may be
attributed to serum GPCA positivity, TGA/TMA positivity,
and/or the disease of EOLP itself. To elucidate these
equivocal probabilities, we compared the blood data be-
tween 29 GPCAþ/TGA/TMA/EOLP patients and 80 GPCA/
TGA/TMA/EOLP patients. GPCAþ/TGA/TMA/EOLP patients
had significantly lower serum vitamin B12 level and signif-
icantly higher MCV and higher serum homocysteine level, as
well as significantly greater frequencies of vitamin B12
deficiency and of high serum homocysteine level than
GPCA/TGA/TMA/EOLP patients had. These findings indi-
cate that serum GPCA positivity plays an important role in
causing vitamin B12 deficiency and higher MCV and higher
homocysteine level in GPCAþ/TGA/TMA/EOLP patients.
This study also found that GPCA/TGA/TMA/EOLP patients
had significantly lower mean Hb, MCV, and serum iron (for
women only) levels, as well as significantly greater fre-
quencies of Hb and iron deficiency than healthy control
individuals had. However, there were no significant differ-
ences in frequencies of blood Hb, iron, vitamin B12, and
folic acid deficiencies and of high serum homocysteine level
between GPCA/TGA/TMA/EOLP patients and Abs/EOLP
patients. These findings indicate that TGA/TMA positivitydoes not play a significant role in causing anemia and he-
matinic deficiencies in GPCA/TGA/TMA/EOLP patients.
We also found that Abs/EOLP patients did have signifi-
cantly lower MCV and lower mean blood Hb, iron (women
only), vitamin B12, and folic acid levels, as well as signifi-
cantly greater frequencies of Hb and iron deficiency than
healthy control individuals had. These findings indicate that
the disease of ELOP itself plays a significant role in causing
anemia and hematinic deficiencies (especially iron defi-
ciency) in GPCA/TGA/TMA/EOLP patients and Abs/EOLP
patients.
Serum GPCA can induce destruction of gastric parietal
cells, resulting in failure of intrinsic factor production and
vitamin B12 deficiency that finally leads to macrocytosis
and the status of pernicious anemia.2e5 Moreover, our
previous studies demonstrated that vitamin B12 and folic
acid deficiencies can lead to high serum homocysteine level
in oral mucosal disease patients.8e10 Supplementation of
multiple B vitamins, especially vitamin B12 and folic acid,
can reduce the serum homocysteine levels in patients with
AG or BMS.28,29
By definition, EOLP patients have bilateral erosive or
ulcerative lesions on multiple oral mucosal sites. These
lesions may cause burning sensation and pain of the lesional
oral mucosae when the patients eat salty and spicy food
stuffs. In addition, our EOLP patients had a mean age of
53e57 years. Older patients may have relatively lower
metabolic rate than younger persons, and thus they need
less energy to support their daily life. These two reasons
result in reduced food intake that in turn leads to anemia
and hematinic deficiencies in a minority of our EOLP pa-
tients. In addition, a small number of our EOLP patients
may possibly have slightly suppressed bone marrow
1010 J.Y.-F. Chang et al.function due to the old age; this further causes anemia in a
minority of our EOLP patients.
Of the 29 GPCAþ/TGA/TMA/EOLP patients, 8 produced
macrocytic RBCs, 18 normocytic RBCs, and 3 microcytic
RBCs. Moreover, 9 (31.0%) of the 29 GPCAþ/TGA/TMA/EOLP
patients had anemia.23,24 Of the nine anemic GPCAþ/TGA/
TMA/EOLP patients, six had pernicious anemia,14e16 two
had iron deficiency anemia (1 had concomitant vitamin B12
deficiency),24 and one had microcytic anemia but did not
have iron deficiency.25 GPCA-positive EOLP patients are
supposed to have vitamin B12 deficiency, which in turn,
results in generation of macrocytic RBCs and pernicious
anemia.14e16 However, we showed that only 9 (31.0%), 8
(27.6%), and 6 (20.7%) of 29 GPCAþ/TGA/TMA/EOLP pa-
tients, only 13 (31.7%), 12 (29.3%), and 3 (7.3%) of 41
GPCAþ/EOLP patients (unpublished data), and only 27
(29.3%), 24 (26.1%), and 13 (14.1%) of 92 GPCAþ/EOLP pa-
tients with desquamative gingivitis had vitamin B12 defi-
ciency, macrocytosis, and pernicious anemia,
respectively.11 We also found that six (66.7%) of nine
vitamin B12-deficient GPCAþ/TGA/TMA/EOLP patients and
six (75.0%) of eight macrocytosis GPCAþ/TGA/TMA/EOLP
patients had pernicious anemia. We also found that 3
(23.1%) of 13 vitamin B12-deficient GPCAþ/EOLP patients
and 3 (25.0%) of 12 macrocytosis GPCAþ/EOLP patients had
pernicious anemia (unpublished data). Moreover, 13 (48.1%)
of 27 vitamin B12-deficient GPCAþ/EOLP patients with
desquamative gingivitis and 13 (54.2%) of 24 macrocytosis
GPCAþ/EOLP patients with desquamative gingivitis had
pernicious anemia.11 Furthermore, our previous studies also
discovered that 16 (12.9%) of 124 GPCA-positive, 17 (18.9%)
of 90 vitamin B12 deficiency, and 10 (16.7%) of 60 macro-
cytosis patients with oral mucosal diseases (including AG,
BMS, OLP, and RAS) had pernicious anemia.14e16 These
findings indicate that not all GPCA-positive, vitamin B12
deficiency, and macrocytosis patients have pernicious
anemia. Moreover, the frequency of patients with GPCA
positivity, vitamin B12 deficiency, or macrocytosis to con-
tract pernicious anemia is associated with disease type and
severity.11,14e16 Indeed, statistical analyses of the afore-
mentioned data indicate that GPCAþ/TGA/TMA/EOLP pa-
tients and desquamative gingivitis-positive GPCAþ/EOLP
patients (but not GPCAþ/EOLP patients without desqua-
mative gingivitis) with vitamin B12 deficiency or macrocy-
tosis had a significantly higher frequency to contract
pernicious anemia than oral mucosal disease patients
with vitamin B12 deficiency or macrocytosis,
respectively.11,14e16
This study found microcytosis in three GPCAþ/TGA/
TMA/EOLP patients; two of them had iron deficiency ane-
mia, including one with concomitant vitamin B12 defi-
ciency. These two iron deficiency patients had severe iron
deficiency (serum iron levelZ 25 mg/dL). The severe iron
deficiency may have played an important role in generation
of microcytic RBCs in these two iron deficiency anemia
patients.23,24 In addition, both iron and vitamin B12 de-
ficiencies may have been the contributing factors causing
anemia in these two iron deficiency anemia patients.15,24
Moreover, of our 11 microcytosis GPCA/TGA/TMA/EOLP
patients, four had iron deficiency anemia and three had
thalassemia trait.24,27 The microcytosis in these four irondeficiency anemia patients (serum iron level< 35 mg/dL)
was due to iron deficiency and the microcytosis in three
thalassemia trait patients was due to Hb gene mutation
that resulted in insufficient production of Hb in RBCs.24,27
In this study, 18 of 29 GPCAþ/TGA/TMA/EOLP patients
had normocytosis. Of the 18 normocytosis patients, none
had Hb, iron, vitamin B12, and folic acid deficiencies.
Moreover, of 68 normocytosis GPCA/TGA/TMA/EOLP pa-
tients, 10 had Hb deficiency (8 had concomitant iron defi-
ciency), 9 had iron deficiency, and none had vitamin B12 or
folic acid deficiency. In addition, of 177 normocytosis Abs/
EOLP patients, 30 had Hb deficiency (12 had concomitant
iron deficiency), 17 had iron deficiency, 1 had vitamin B12
deficiency, and 1 had folic acid deficiency. The normal
vitamin B12 and folic acid levels and only a small per-
centage (9.9%) of our patients with iron deficiency may be
the major factors resulting in normocytosis in our 18
GPCAþ/TGA/TMA/EOLP patients, 68 GPCA/TGA/TMA/
EOLP patients, and 177 Abs/EOLP patients.11
In this study, 20 (69.0%) of our 29 GPCAþ/TGA/TMA/
EOLP patients did not have vitamin B12 deficiency. GPCAþ/
TGA/TMA/EOLP patients may tend to have intrinsic factor
deficiency that finally results in vitamin B12 deficiency.14e16
It has been explained why some GPCA-positive oral mucosal
disease patients do not have vitamin B12 deficiency in our
previous studies.11,14 Even in patients who have GPCA
positivity, high-dose oral vitamin B12 supplement therapy
can correct the vitamin B12 deficiency state. In addition,
some GPCA-positive oral mucosal disease patients may still
have enough residual gastric parietal cells that can produce
intrinsic factors and in turn help to absorb vitamin B12 from
the small intestine.4,30
We conclude that both serum GPCA positivity and EOLP
itself are the contributing factors causing anemia and he-
matinic deficiencies in GPCAþ/TGA/TMA/EOLP patients, but
serum GPCA is the major factor causing vitamin B12 defi-
ciency, macrocytosis, and pernicious anemia in GPCAþ/
TGA/TMA/EOLP patients. ELOP itself but not TGA/TMA
positivity plays a significant role in causing anemia and he-
matinic deficiencies in GPCA/TGAþ/TMAþ/EOLP patients.
Moreover, of 29 GPCAþ/TGA/TMA/EOLP patients, 9 (31.0%)
had vitamin B12 deficiency and 8 (27.6%) had macrocytosis.
Only six (66.7%) of nine vitamin B12-deficient GPCAþ/TGA/
TMA/EOLP patients and six (75.0%) of eight macrocytosis
GPCAþ/TGA/TMA/EOLP patients had pernicious anemia.
Therefore, in addition to pernicious anemia (20.7%), GPCAþ/
TGA/TMA/EOLP patients may also have iron deficiency
anemia (6.9%) and microcytic anemia (3.4%).Conflicts of interest
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